News & Events

Gothenburg-based Omaia has closed an oversubscribed pre-seed round backed by angel investors, reflecting growing investor interest in women’s health – a historically underfunded area despite significant unmet needs.

Mirno, originally incubated at Co-AX Accelerator at Sahlgrenska Science Park, has won the HealthTech Award 2026 for its virtual patient technology, recognised for advancing the way healthcare professionals train, practise and make clinical decisions.

Vitalis is the Nordic region's leading meeting place for the future of health, care and Sahlgrenska Science Park at Vitalis representing Sweden innovations to showcase future of health innovation.

Germany offers significant opportunities for Swedish MedTech companies, but entering the market requires a strong understanding of the healthcare system, local partnerships, and successful pilot implementation. 

On 4 March, investors, entrepreneurs and industry leaders will gather at Wallenberg Conference Centre, Sahlgrenska Academy, as Life Science Day marks its 10th anniversary.

In the report’s “State of the Industry” section, Emma Hallenberg, Director of Co-Ax Accelerator at Sahlgrenska Science Park, shares insights on the evolving landscape for life science innovation in Gothenburg and Sweden.

Several companies within Sahlgrenska Science Park have recently reached significant milestones, including a strategic acquisition and substantial capital secured to advance late-stage clinical trials in Europe and the United States.

Companies at CO-AX accelerator focusing on important sides of building a startups - Market, Clinical trials, Clinical studies.

VERIGRAFT AB today announce a committed capital contribution of SEK 110 million from an existing long-term shareholder.

Sightic, which develops technology to detect impairment states through the analysis of eye movements and behavioral patterns, has been acquired by Smart Eye in a deal valued at just over SEK 60 million.

CEO Cecilia Edebo will serve as a jury member at TechArena 2026.

Two companies from Sahlgrenska Science Park’s CO-AX portfolio, BrainLink Health and TrialMe, have been selected among the Top 46 startups at TECHARENA 2026.